UK-based pharmaceutical company Phagenesis closed its €7m ($9.3m) of series B funding yesterday with Inventages, a life sciences firm backed by Switzerland-based food and nutrition corporation Nestlé, leading the round. Founded in 2007 after it span off from research performed at the University of Manchester, Phagenesis raised £2m ($3.1m) in a September 2010 series A round of financing from unnamed investors. Phagenesis is developing a device that will help dysphagia sufferers to swallow, using controlled electrical pulses. Gunnar Weikert, founder of Inventages, said: "Phagenesis is addressing a critical, unmet need in a very large market. Dysphagic patients are underserved by modern medicine and many face tube-feeding and a significant loss of quality of life for decades. Phagenesis is ideally placed to meet this challenge." Ashok Dhanrajgir, senior partner at Inventages, added: "We are optimistic that Phagenesis will demonstrate further clinical evidence on efficacy and health economic benefits to society."
- News & Analysis
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Deal Data
- Community & Events
Inventages backs Phagenesis
Oct 5, 2011 • Robert Lavine
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Featured ContentFUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.
FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.NOMINATE Nominations for the GCV Powerlist 2024 are now open
Nominations for the GCV Powerlist 2024 are now openEventsWebinar: Startups and Strategics – What works and what doesn’tEventsGCV Institute: Landing the Value of Corporate VenturingTop News
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.test reg